Apellis Pharmaceuticals Inc EBIT margin
Cos'è EBIT margin di Apellis Pharmaceuticals Inc?
EBIT margin di Apellis Pharmaceuticals Inc è -47.70%
Qual è la definizione di EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin di aziende nel Health Care settore su NASDAQ rispetto a Apellis Pharmaceuticals Inc
Cosa fa Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Aziende con ebit margin simili a Apellis Pharmaceuticals Inc
- Ortel Communications ha EBIT margin di -48.44%
- Carespan Health Inc ha EBIT margin di -48.23%
- Premier Veterinary plc ha EBIT margin di -48.18%
- KBS Fashion ha EBIT margin di -47.93%
- WPX Inc ha EBIT margin di -47.81%
- A2Z Infra Engineering ha EBIT margin di -47.75%
- Apellis Pharmaceuticals Inc ha EBIT margin di -47.70%
- Global Offshore Services ha EBIT margin di -47.46%
- Rde Inc ha EBIT margin di -47.41%
- Veritone Inc ha EBIT margin di -47.20%
- My Size Inc ha EBIT margin di -46.99%
- Krebs Biochemicals & Industries ha EBIT margin di -46.98%
- First Seacoast Bancorp ha EBIT margin di -46.95%